[Federal Register Volume 78, Number 100 (Thursday, May 23, 2013)]
[Notices]
[Pages 30933-30934]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2013-12254]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications/contract proposals and the 
discussions could disclose confidential trade secrets or commercial 
property such as patentable material, and personal information 
concerning individuals associated with the grant applications, the 
disclosure of which would constitute a clearly unwarranted invasion of 
personal privacy.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Topic 306 Development of Innovative Algorithms/Software for 
Processing & Analysis of In Vivo Images in Oncology.
    Date: June 14, 2013.
    Time: 1:00 p.m. to 4:00 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Cancer Institute Shady Grove, Shady Grove, 9609 
Medical Center Drive, Room 4W032 ,Rockville, MD 20850, (Telephone 
Conference Call).
    Contact Person: Clifford W Schweinfest, Ph.D., Scientific Review 
Officer, Special Review and Logistics Branch, Division of Extramural 
Activities, National Cancer Institute, 9609 Medical Center Drive, 
Room 7W108, Bethesda, Md 20892-9750, 240-276-6378, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Nanotech-Biosensor Platforms for Cancer.
    Date: June 19, 2013.
    Time: 3:00 p.m. to 5:00 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Cancer Institute Shady Grove, Shady Grove, 9609 
Medical Center Drive, Room 6W032, Rockville, MD 20850, (Telephone 
Conference Call).
    Contact Person: Christopher L. Hatch, Ph.D., Chief, Health 
Scientist Administrator, Program Coordination and Referral Branch, 
Division of Extramural Activities, National Cancer Institute, NIH, 
9609 Medical Center Drive, Room 7W554, Bethesda, MD 20892-9750, 240-
276-6454, [email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Development of Glycosylation-Specific Research Reagents 
(Antibodies and Aptamers).
    Date: July 2, 2013.
    Time: 10:00 a.m. to 2:30 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Cancer Institute Shady Grove, Shady Grove, 9609 
Medical Center Drive, Room 7W034, Rockville, MD 20850, (Telephone 
Conference Call).
    Contact Person: Marvin L. Salin, Ph.D., Scientific Review 
Officer, Special Review and Logistics Branch, Division of Extramural 
Activities, National Cancer Institute, NIH, 9609 Medical Center 
Drive, Room 7W236, Bethesda, MD 20892-9750, 240-276-6369, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; T32 Application Review.
    Date: July 8, 2013.
    Time: 12:00 p.m. to 2:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute Shady Grove, Shady Grove, 9609 
Medical Center Drive, Room 7W030, Rockville, MD 20850, (Telephone 
Conference Call).
    Contact Person: Robert Bird, Ph.D., Chief, Resources and 
Training Review Branch, Division of Extramural Activities, National 
Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W110, 
Bethesda, MD 20892-9750, 240-276-6344, [email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Utilizing the PLCO Biospecimens Resource to Bridge Gaps in 
Cancer Etiology & Early Detection.
    Date: July 9, 2013.
    Time: 12:00 p.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute Shady Grove, Shady Grove, 9609 
Medical Center Drive, Room 7W034, Rockville, MD 20850, (Telephone 
Conference Call).
    Contact Person: Donald L Coppock, Ph.D., Scientific Review 
Officer, Special Review and Logistics Branch, Division of Extramural 
Activities, National Cancer Institute, NIH, 9609 Medical Center 
Drive, Room 7W260, Bethesda, MD 20892, 240-276-6382, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Validation and Advanced Development of Emerging Molecular 
Analysis Technologies for Cancer Research.
    Date: July 17, 2013.
    Time: 12:00 p.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute Shady Grove, Shady Grove, 9609 
Medical Center Drive, Room 7W034, Rockville, MD 20850, (Telephone 
Conference Call).
    Contact Person: Timothy C. Meeker, MD, Ph.D., Scientific Review 
Officer, Resources and Training Review Branch, Division of 
Extramural Activities, National Cancer Institute, NIH, 9609 Medical 
Center Drive, Room 7W606, Bethesda, MD 20892, 240-276-6454, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Feasibility Studies to Build Collaborative Partnerships in 
Cancer Research.
    Date: July 23, 2013.
    Time: 10:00 a.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute Shady Grove, Shady Grove, 9609 
Medical Center Drive, Room 5W030, Rockville, MD 20850, (Telephone 
Conference Call).
    Contact Person: Gerald G. Lovinger, Ph.D., Scientific Review 
Officer, Special Review and Logistics Branch, Division of Extramural 
Activities, National Cancer Institute, 9609 Medical Center Drive, 
Room 7W266, Bethesda, MD 20892-8329, 240-276-6385, 
[email protected].

    Information is also available on the Institute's/Center's home 
page: http://deainfo.nci.nih.gov/advisory/sep/sep.htm, where an 
agenda and any additional information for the meeting will be posted 
when available.

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)



[[Page 30934]]


    Dated: May 17, 2013.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2013-12254 Filed 5-22-13; 8:45 am]
BILLING CODE 4140-01-P